SAGA diagnostics AB   Report issue

For profit Phase 2
Founded: Lund Sweden (2016)
Status: No NME R&D (2016)

Organization Overview

First Clinical Trial
2019
NCT03883802
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

SAGA diagnostics AB

Active Ingredients

Drugs in Phase 2 Trials (4)

fluorouracil (efudex) (1 trial)

foxy-5 (1 trial)

leucovorin (1 trial)

oxaliplatin (eloxatin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colonic Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 4